Rheos Capital Works’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-258,165
| Closed | -$17.9M | – | 103 |
|
|
2023
Q3 | $17.9M | Buy |
258,165
+100,000
| +63% | +$6.93M | 1.08% | 33 |
|
|
2023
Q2 | $14.9M | Hold |
158,165
| – | – | 0.8% | 41 |
|
|
2023
Q1 | $13.1M | Sell |
158,165
-22,000
| -12% | -$1.82M | 0.73% | 52 |
|
|
2022
Q4 | $13.4M | Hold |
180,165
| – | – | 0.81% | 44 |
|
|
2022
Q3 | $14.9M | Hold |
180,165
| – | – | 1% | 34 |
|
|
2022
Q2 | $17.1M | Hold |
180,165
| – | – | 1.29% | 19 |
|
|
2022
Q1 | $21.2M | Hold |
180,165
| – | – | 1.02% | 33 |
|
|
2021
Q4 | $23.3M | Hold |
180,165
| – | – | 1.02% | 30 |
|
|
2021
Q3 | $20.4M | Hold |
180,165
| – | – | 1.05% | 31 |
|
|
2021
Q2 | $18.7M | Buy |
180,165
+25,000
| +16% | +$2.59M | 0.94% | 35 |
|
|
2021
Q1 | $13M | Buy |
155,165
+20,000
| +15% | +$1.67M | 0.86% | 42 |
|
|
2020
Q4 | $12.3M | Hold |
135,165
| – | – | 0.9% | 35 |
|
|
2020
Q3 | $10.8M | Hold |
135,165
| – | – | 0.88% | 25 |
|
|
2020
Q2 | $9.34M | Buy |
135,165
+17,400
| +15% | +$1.2M | 0.65% | 29 |
|
|
2020
Q1 | $7.4M | Buy |
+117,765
| New | +$7.4M | 0.79% | 24 |
|